ULK1 and liver cancer: Systemic KO of Ulk1 prevented liver cancer and reduced hepatic tumor growth in a diethylnitrosamine (DEN)-induced hepatocellular carcinoma (HCC) model, suggesting that ULK1 may be a target for treating liver cancer [51].